Department of Medicine 4 – Nephrology and Hypertension

Personalized Drug Response: IMplementation and Evaluation in CKD (PRIME-CKD) Personalized Drug Response: IMplementation and Evaluation in CKD Jan. 1, 2023 - Dec. 31, 2027 J114: Profiling of transcriptional regulatory circuitries in the development of clear cell renal cell carcinoma Aug. 1, 2024 - Sept. 30, 2027 "Glomerular-specific targeting with funtionalized drug loaded nanoparticles for precision medicine in glomerular diseases" (M4-EKFS_2023_EKSE.70) Aug. 1, 2024 - July 31, 2027 Glomerular-specific targeting with functionalized drug loaded nanoparticles for precision medicine in glomerular diseases (EKFS) June 1, 2024 - May 31, 2027 Die Rolle des Lipoprotein-Rezeptor-Proteins 1 (LRP1) bei akuter Nierenschädigung (A08*) (SFB/TRR 374 A08) TRR 374: Tubulussystem und Interstitium der Niere: (Patho-)Physiologie und Crosstalk Jan. 1, 2023 - Dec. 31, 2026 Glomerular to tubular crosstalk through miR-containing exosomes (SFB TRR 374 A9-N) Tubulussystem und Interstitium der Niere: (Patho-) Physiologie und Crosstalk Jan. 1, 2023 - Dec. 31, 2026 Die Rolle von Feinstaub und Mikro-/ Nanoplastik in glomerulären Erkrankungen mit einem besonderen Fokus auf membranöser Glomerulonephritis (UNPLOK) June 17, 2023 - June 16, 2026 P173: Lymphocyte immune assays as biomarker for kidney transplanted patients under immunosuppression in sepsis May 15, 2025 - May 14, 2026 P187: Unraveling the diversity of PAX2-associated kidney disease using patient-derived in vitro models Nov. 1, 2025 - April 30, 2026 P149: Podocyte specific targeting with functionalized drug loaded nanoparticles for precision medicine Jan. 1, 2025 - Dec. 31, 2025